EUVIMEDEUVIMED entdecken
Fallbericht

Mammosomatotroph pituitary neuroendocrine tumour in a 7-year-old boy: case report

Wei Lin, Yadan Qiu, Zhuang Ma, Hongyao Yuan, Rui Yang, Xinke Xu

Child's Nervous System · 17.03.2026 · 42 (1)

DOI: 10.1007/s00381-026-07203-1 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Child's Nervous System, online erschienen am 17.03.2026. Verfasst von Wei Lin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, 318, Ren Min Zhong Lu, Guangzhou, 510120, Ch…. Hauptthemen laut MEDLINE: Pituitary Neoplasms, Neuroendocrine Tumors. Die Arbeit nennt 22 Literaturangaben. Gefördert von: Science & Technology Project of Guangzhou Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Pituitary neuroendocrine tumours (PitNETs) of the mammosomatotroph type are exceedingly rare in childhood, particularly in children under 10 years old. Existing high-quality, evidence-based data primarily derive from large adult cohorts, while paediatric evidence remains extremely limited. Case presentation A 7-year-old boy presented with headaches, transient amaurosis, and accelerated linear growth (+3.0 SDS), clinically consistent with pituitary gigantism. MRI revealed a 1.9 × 1.7 × 2.8 cm predominantly cystic sellar-suprasellar mass compressing the optic chiasm, radiologically indistinguishable from craniopharyngioma. Preoperative biochemistry showed GH > 40 ng/mL, IGF-1 = 479 ng/mL (reference range: 40-255 ng/mL), and PRL = 129 ng/mL (reference range: 2.1-17.7 ng/mL). Transcranial gross-total resection normalized GH (5.15 ng/mL), PRL (9.56 ng/mL), and IGF-1 (257 ng/mL) without adjuvant medical therapy. Histology confirmed a paediatric case of mammosomatotroph PitNETs. Targeted next-generation sequencing detected a pathogenic SMARCB1 deletion but no AIP, GNAS, or USP8 variants. The patient remains clinically and biochemically well 8 months postoperatively. CONCLUSIONS: This 7-year-old boy represents one of the youngest recorded cases of a mammosomatotroph pituitary neuroendocrine tumour. The atypical presentation, dominated by mass-effect symptoms and pituitary gigantism, highlights the necessity of early hormonal and genetic screening when evaluating complex paediatric sellar masses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pituitary NeoplasmsNeuroendocrine TumorsHumansMaleChild

Stichwörter der Autor:innen

Growth hormoneMammosomatotrophPaediatricPituitary neuroendocrine tumourProlactin

Autor:innen und Institutionen

  • Department of Neurosurgery, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, 318, Ren Min Zhong Lu, Guangzhou, 510120, China.
  • Department of Neurosurgery, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, 318, Ren Min Zhong Lu, Guangzhou, 510120, China. ryanfezx@163.com.
  • Department of Neurosurgery, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, 318, Ren Min Zhong Lu, Guangzhou, 510120, China. sjwkxxk@163.com.

Förderung

  • Science & Technology Project of Guangzhou Municipality

Zitieren

APA

Lin, W., Qiu, Y., Ma, Z., Yuan, H., Yang, R., & Xu, X. (2026). Mammosomatotroph pituitary neuroendocrine tumour in a 7-year-old boy: case report. Child's Nervous System, 42(1). https://doi.org/10.1007/s00381-026-07203-1

Vancouver

Lin W, Qiu Y, Ma Z, Yuan H, Yang R, Xu X. Mammosomatotroph pituitary neuroendocrine tumour in a 7-year-old boy: case report. Child's Nervous System. 2026;42(1). doi:10.1007/s00381-026-07203-1

BibTeX
@article{Lin2026,
  author = {Lin, Wei and Qiu, Yadan and Ma, Zhuang and Yuan, Hongyao and Yang, Rui and Xu, Xinke},
  title = {Mammosomatotroph pituitary neuroendocrine tumour in a 7-year-old boy: case report},
  journal = {Child's Nervous System},
  year = {2026},
  volume = {42},
  number = {1},
  doi = {10.1007/s00381-026-07203-1}
}
Kostenlos starten →